CARE vs CCNE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CARE

63.4
AI Score
VS
CARE Wins

CCNE

56.6
AI Score

Investment Advisor Scores

CARE

63score
Recommendation
STRONG BUY

CCNE

57score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE CCNE Winner
Forward P/E 13.6612 10.1215 CCNE
PEG Ratio 0 1.0613 Tie
Revenue Growth 68.3% 51.0% CARE
Earnings Growth 253.9% 49.2% CARE
Tradestie Score 63.4/100 56.6/100 CARE
Profit Margin 44.9% 29.2% CARE
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY BUY CARE

Relative Price Performance (Last 90 Days)

CARE 1M: +2.6% · 3M: -9.7% CCNE 1M: +5.4% · 3M: +1.6%

Current Technical Phase

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.2 · Price: $30.70

CCNE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $35.24

Fundamentals Snapshot

Metric CARE CCNE
Market Cap — —
Forward P/E 11.8 9.4
Trailing P/E 5.2 10.7
Revenue (TTM) — —
Revenue Growth 0.7% 0.5%
Gross Margin 1.0% 1.0%
Operating Margin 0.6% 0.4%
EPS 5.83 3.24
Dividend Yield 0.00% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.